Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 26Colorectal Neoplasms 17Colonic Neoplasms 15Central Nervous System Neoplasms 15Rectal Neoplasms 11Glioblastoma 7Lung Neoplasms 6Kidney Neoplasms 6Gliosarcoma 6Carcinoma, Non-Small-Cell Lung 6Brain Neoplasms 6Astrocytoma 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Sarcoma 4Neoplasm Metastasis 4Melanoma 4Fallopian Tube Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Glioma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2

Interventions

Specimen Handling 17Magnetic Resonance Spectroscopy 15Gemcitabine 13Cisplatin 8Biopsy 8Radiotherapy 7Mitomycin 6Cystoscopy 6pembrolizumab 5Trastuzumab 5Paclitaxel 5Fluorouracil 5cabozantinib 4atezolizumab 4Radiation 4erdafitinib 3dehydroftorafur 3Transurethral Resection of Bladder 3Sunitinib 3Sorafenib 3Platinum 3Nivolumab 3Mitozytrex 3Gene Expression Profiling 3Fluorodeoxyglucose F18 3Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3valrubicin 2tipifarnib 2sapanisertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Urinary Bladder Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00054626 2013-12-18

Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
700 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00028860 2013-07-10

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡